An interventional study of M-Health through Mobile Application and Telerehabilitation in Subacromial Pain Syndrome, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
This study will compare M-Health rehabilitation delivered through the Physitrack application, telerehabilitation delivered through supervised online video sessions, and conventional face-to-face physiotherapy in adults with Subacromial Pain Syndrome. The planned sample is 51 participants, with 17 participants in each group. The intervention will last 6 weeks. Pain, Shoulder pain and disability, and shoulder range of motion will be assessed at baseline, Week 3, and Week 6 using NPRS, SPADI and universal Goniometer. Exercise adherence will be monitored during the intervention and assessed at Week 6 using EARS; patient satisfaction will be assessed at Week 6 using CSQ-8.
Subacromial Pain Syndrome is a common musculoskeletal shoulder condition associated with lateral shoulder pain, particularly during overhead activities, reduced shoulder mobility, and weakness of the rotator cuff and scapular stabilizers. This study proposes to compare three modes of rehabilitation delivery: a mobile-health program through the Physitrack application, therapist-supervised telerehabilitation using an online video platform, and conventional in-person physiotherapy. The synopsis specifies a quasi-experimental design and convenience sampling, with a planned sample of 51 participants aged 18-45 years, allocated as 17 participants per group. All groups will follow the described progressive shoulder exercise protocol over 6 weeks, with delivery and supervision differing by group. The primary outcomes are pain intensity and shoulder pain/disability. Secondary outcomes include shoulder range of motion, exercise adherence, and patient satisfaction. NPRS, SPADI, and a universal goniometer will be used at baseline, Week 3, and Week 6; EARS and CSQ-8 will be used for adherence and satisfaction assessment at Week 6.
735 studies on the registry are indexed under Shoulder Pain; 167 are open to participants now.
This study's planned enrollment of 51 is below the median of 60 across 587 interventional studies indexed under Shoulder Pain.
Browse Shoulder Pain studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults aged 18-45 years.
Exclusion Criteria:
History of shoulder surgery or fracture within the past 6 months.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Home exercise and rehabilitation plan delivered through the Physitrack mobile application.
Other: M-Health through Mobile Application
Therapist-supervised online video sessions plus home-based exercises.
Other: Telerehabilitation
In-person physiotherapy sessions at the rehabilitation center plus a home exercise program.
Other: Conventional Physiotherapy
After baseline assessment, participants will be trained to use the Physitrack patient interface. The prescribed exercise program, educational material, reminders, and progression guidelines will be uploaded to the app. Participants will perform the exercises independently at home for 6 weeks. Weekly monitoring and adherence tracking will be conducted through the application. Frequency/delivery: Home plan through the app 7 days per week for 6 weeks.
Participants will receive physiotherapy supervision through video calls twice weekly. The therapist will monitor exercise performance, provide corrections, and progress the exercise program as needed. On the remaining days, participants will independently perform the prescribed home exercises. Frequency/delivery: 2 supervised video sessions and 5 home-exercise days per week for 6 weeks.
Participants will receive face-to-face physiotherapy at the rehabilitation center. During weeks 1-2, participants will attend supervised sessions 3 times per week. During weeks 3-6, participants will attend sessions twice weekly. On non-clinic days, they will continue the prescribed home exercise program independently.
Numeric Pain Rating Scale (NPRS)
An 11-point self-reported scale for pain intensity, where 0 indicates no pain and 10 indicates the worst imaginable pain. It is valid and reliable (ICC approximately 0.86), with a minimal clinically important difference of 1-2 points.
Time frame: Baseline (Week 0), Week 3, and Week 6.
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
Of 349 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 8 months is below that.
Counting every sponsor, half of 354 studies reached it within 11 months; a quarter within 4 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →